Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlantech International is a medical device company specializing in the development and distribution of advanced orthopedic surgical solutions. The company is best known for its Ligament Advanced Reinforcement System (LARS), a range of synthetic ligaments designed for the reconstruction of ruptured ligaments, particularly the anterior cruciate ligament (ACL). These products are engineered to mimic the natural fibers of ligaments while providing a scaffold for soft tissue ingrowth. In 2014, the company was acquired by Corin Group, a global orthopedic manufacturer, to enhance its soft tissue repair portfolio. Atlantech's technology focuses on reducing recovery times and improving clinical outcomes for sports medicine and orthopedic patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atlantech International.